3,4-Dimethoxybenzimidamide hydrochloride

Catalog No.: 
ACZTEP069
CAS No.: 
51488-33-6
Molecular Formula: 
C9H13ClN2O2
Molecular Weight: 
216.67
3,4-Dimethoxybenzimidamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%
5g98%
10g98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,4-Dimethoxybenzimidamide hydrochloride
IUPAC Name3,4-dimethoxybenzimidamide hydrochloride
MDL No.MFCD01667882
Molecular FormulaC9H13ClN2O2
Molecular Weight216.67
SMILESN=C(N)C1=CC=C(OC)C(OC)=C1.[H]Cl
InChI KeyJTKNCRAAATVMFV-UHFFFAOYSA-N
Synonym3,4-DIMETHOXY-BENZAMIDINE HCL;3,4-DIMETHOXY-BENZAMIDINE HYDROCHLORIDE;3,4-dimethoxy-benzamidinmonohydrochloride;3,4-dimethoxybenzimidamide hydrochloride;3,4-dimethoxybenzenecarboximidamide hydrochloride;3,4-dimethoxybenzene-1-carboximidamide hydrochloride
CAS No.51488-33-6
PubChem CID13165335

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACZTEP069 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEOPF786 route compound structure diagram
    ACEOPF7861521-41-1In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACZTEP069 route product structure diagram
    ACZTEP06951488-33-6In Stock
Inquiry

2. ACZTEP069 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZTEP069 route product structure diagram
    ACZTEP06951488-33-6In Stock
Inquiry

3. ACZTEP069 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZTEP069 route product structure diagram
    ACZTEP06951488-33-6In Stock
Inquiry

Comments (0)